Skip to main content
. Author manuscript; available in PMC: 2010 May 1.
Published in final edited form as: Health Aff (Millwood). 2009 May–Jun;28(3):701–712. doi: 10.1377/hlthaff.28.3.701

Exhibit 2.

Percent* of persons with self-reported schizophrenia using each drug during the study year (n=237)

Atypical Antipsychotic Drug Percent with use in 1996/1997 Percent with use in 2004/2005 Growth in use (2004/2005 / 1996/1997)
Clozapine 3.9% (2.4) 4.8% (2.9) 21.7%
Olanzapine 12.1% (3.6) 35.0% (6.2) 189.9%
Quetiapine -- 14.4% (4.6) --
Risperidone 12.9% (4.9) 19.4% (4.6) 51.2%
Ziprasidone -- 10.1% (3.7) --
Aripiprazole
--
15.6% (4.4)
--
Any 26.7% (6.6) 75.2% (5.0) 181.9%
*

Percents reflect percentage of people reporting one or more filled prescriptions during the year (quetiapine, ziprasidone, and aripiprazole were not available in 1996/1997). Persons may report use of more than one medication, so sum of percents is over 100%. Figures in parentheses are linearized standard errors.

Source: Authors’ calculations from 1996−2005 Medical Expenditure Panel Survey (pooled weights).